This announcement details the company's decision to utilize idle funds for entrusted wealth management, with a maximum investment amount of 40 million yuan. The investment period is set to not exceed 12 months, with expected annualized returns ranging from 1.10% to 1.75%. The company aims to enhance financial performance while ensuring compliance with relevant regulations.
Summary generated by AI · Always verify with source document
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") held the 2025 Annual General Meeting on October 30, 2025. During the meeting, it was proposed to utilize idle self-owned funds for entrusted wealth management. The Company and its board of directors ensure that the information disclosed is true, accurate, and complete, without any false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.